Perbedaan Organon Pharma Indonesia Tbk. dan Saratoga Investama Sedaya Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Saratoga Investama Sedaya Tbk. diperdagangkan di Rp1.805 (kapitalisasi pasar 24,69 T, volume 24 jam 1,91 jt). Perbedaan utamanya: Saratoga Investama Sedaya Tbk. jauh lebih besar — sekitar 236,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SRTG | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 24,69 T |
Volume | — | 1,91 jt |
Lot | — | 19,14 rb |
Perputaran | — | 3,44 M |
Harga Rata-rata | — | 1.795,96 |
Nilai Transaksi | — | 3,44 M |
Harga Ekuilibrium Indikatif | — | 1.805 |
Volume Ekuilibrium Indikatif | — | 422 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Saratoga Investama Sedaya Tbk (the Company) was established in Jakarta based on Notarial Deed No. 41 dated May 17, 1991 in conjuction with Notarial Deed No.33 dated July 13 1992, both of Ny. Rukmasanti Hardjasatya, SH., Notary in Jakarta.
Selengkapnya di halaman SRTG →